PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy. The Drug Policy Alliance (DPA). The Drug Policy Alliance (DPA).

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy. The Drug Policy Alliance (DPA). The Drug Policy Alliance (DPA).

Policy 40

Policy DEA Access Media 40

CannaMD

SEPTEMBER 15, 2020

MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. To learn more about telehealth appointments and CannaMD ‘s COVID-19 safety measures, see: Coronavirus Policies.

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

FEBRUARY 28, 2022

Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline , 10 FRONTIERS PSYCHIATRY 1, 2 (2019). Feduccia et al., 21 × 21.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

SpeedWeed

AUGUST 19, 2021

In recent months, a synthetic compound derived from hemp called THC-O acetate—often referred to simply as THC-O (pronounced “THC oh”)—has quickly gained popularity among Americans who don’t have access to legal cannabis. . THC-O products are increasingly popular in states where consumers don’t have access to legal cannabis.

THC 52

THC Hemp Extraction Vaping 52

SpeedWeed

MARCH 18, 2021

Given the topical nature of the current trial and its relevance for public policy on medical cannabis, participants might have been biased to report positive effects regardless of condition. Wasn’t the DEA going to let others grow research-grade cannabis? It tested at only 9% THC. Research quality” cannabis sparked earlier controversy.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Project CBD

AUGUST 23, 2023

A leading California cannabis industry policy influencer, Devitt is currently Director of Regulatory Affairs at CannaCraft & March and Ash. 9 We cannot assume that these novel compounds are safe based on the safety profile of natural cannabinoids. .” percent on a dry weight basis.”

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder. But only if it is made affordable and accessible.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

NOVEMBER 2, 2021

Testing for Safety: Are Impurities a Problem? The investigation covered a lot of important ground, but the main results concern the levels of delta-9 THC in each product, the inaccuracy of the labeling, how easily minors can get access to products and whether companies test for impurities. Testing for Safety: Are Impurities a Problem?

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

SEPTEMBER 23, 2019

During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Canna Law Blog

MARCH 4, 2020

And as long as the healthcare provider in charge judges the infusion therapy to be ethical and not violative of safety standards, they may prescribe it accordingly. That access would be available under the auspices of having a chronic, untreatable mood disorder.

Therapy 89

Therapy Legalization Chronic Pain DEA 89

Cannabis Law Report

MAY 24, 2022

Substances considered to pose the greatest risk to the public health and safety are subject to the most stringent controls and sanctions. The criminalization of marijuana was the result of racially motivated policies, such as the Marijuana Tax Act of 1937. The Tax Act was litigated in Leary v.

DEA 52

DEA History Medicine Marijuana 52

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Sensi Seeds

NOVEMBER 28, 2018

Then, a blog post circulated online, notifying the industry that Spain’s food and safety authority, AECOSAN, had updated its legislation to prohibit the sale and distribution of products containing CBD being sold as food supplements. Irrespective of where the directive came from, policy on CBD has changed. CBD Regulation is Needed.

CBD 71

CBD Seed-To-Sale Food Research and Development 71

Cannabis Law Report

JUNE 1, 2021

A replay will be accessible by webcast until 11:59 PM ET on August 30, 2021 at: [link]. Drug Enforcement Administration (the “DEA”), the U.S. The Company will host a conference call and audio webcast with David Klein , CEO and Mike Lee , CFO at 10:00 AM Eastern Time on June 1, 2021. Webcast Information.

Data 95

Data Vaping Supply Chain Business 95

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. In some instances, a medical provider or psychotherapist (or both) is present in the treatment room.

Therapy 78

Therapy Access Blood Pressure Treatment 78

Cannabis Law Report

APRIL 24, 2019

Such actions by the federal will create some very difficult paths because of policy distinctions arising from individual rights, public protections, commercial activities, health and safety, use of resources, etc.]. We are not going to attempt to tackle the myriad policy issues of this alternative, but we do have some observations.

Legalization 58

Legalization Collective DEA Banking 58

The Cannigma

SEPTEMBER 12, 2021

This contradiction, combined with a problematic regulatory framework that limits access to THC products in many states, has created a booming market for d-8 and d-10. The safety of using these products however, is still unknown. The first researcher who identified and isolated THC, was the American Roger Adams (Shutterstock).

THC 98

THC Research and Development Cannabinoids CBD 98

Meadow

JULY 13, 2018

Isa Perez (Head of Business Development at Meadow) moderates the Update from Local Regulators Panel with Joe Devlin (Sacramento Cannabis Policy and Enforcement), Cat Packer (Los Angeles Department of Cannabis Regulation), and Nicole Elliot ( San Francisco Office of Cannabis). Photo Credit: Kandid Kush.

Wellness and Beauty 40

Wellness and Beauty Consumption Policy Cannabis 40

Veriheal

DECEMBER 1, 2022

Historically, it has been difficult for cannabis-related businesses to access reliable financial services due to its illegal federal status. This bill also directs the DEA to register manufacturers and distributors of CBD or marijuana for commercial production of an approved drug that contains marijuana or its derivative.

Access 99

Access Banking Policy Legislation 99

Veriheal

FEBRUARY 23, 2024

As the Drug Enforcement Administration (DEA) and federal government draw closer to moving cannabis from a Schedule I to a Schedule III substance , more groups have begun to put their weight behind the movement. Countless veterans suffer from these ailments, and, as such, are pushing for access to as many treatments and therapies as possible.

DEA 84

DEA Chronic Pain Treatment Therapy 84

Cannabis Law Report

AUGUST 6, 2021

A replay will be accessible by webcast until 11:59 PM ET on November 4, 2021 at: [link]. Drug Enforcement Administration (the “DEA”), the U.S. The Company will host a conference call and audio webcast with David Klein , CEO and Mike Lee , CFO at 10:00 AM Eastern Time on August 6, 2021. Webcast Information. Replay Information.

Vaping 105

Vaping Research and Development Data Business 105

Dykema (Cannabis Law Blog)

OCTOBER 6, 2023

From a policy standpoint, there are pros and cons to this approach. On the one hand, this kind of decrim bill arguably democratized access to psychedelics. On the other hand, with no laws or regulations around the production of the plants and fungi, there is no framework for safety or quality control (i.e., What camp are you in?

Consumption 58

Consumption DEA Decriminalization Access 58

The Blunt Truth

MAY 15, 2020

The latest proposal submitted by House Democrats, entitled the HEROES Act, includes a provision that would allow “…access to financial services to cannabis-related legitimate businesses and service providers…” The language is from the SAFE Banking Act passed by the House last year. So let’s get started.

Banking 106

Banking Research and Development Programs Advocacy 106

Canna Law Blog

NOVEMBER 16, 2021

The enforcement role moves from DEA to ATF. When it comes to enforcing federal cannabis regulations, the Drug Enforcement Administration (“DEA”) is out and the Bureau of Alcohol, Tobacco, Firearms, and Explosives (“ATF”) is in (in addition to TTB as the primary overseer). ” SBA fairness.

DEA 87

DEA Business Banking Food 87

Cannabis Law Report

SEPTEMBER 19, 2019

Here are three of the most pressing matters that might give Congress absolutely no choice but to surrender to marijuana legalization in the interest of public health and safety. . This leaves room for further growth, which may occur from the recent legalization of smokable flower and continued wide access to dispensaries.”

Vaping 55

Vaping Hemp Education Patients 55

Cannabis Law Report

MARCH 25, 2019

Both paths are complex processes in which scientific, medical, policy and political forces have influence. There are other avenues Congress can take besides rescheduling marijuana to ameliorate the seeming breakdown in federalism brought about by federal marijuana policy. It was not a policy priority of the Obama administration.

Banking 45

Banking Law Marijuana State Laws 45

Cannabis Law Report

AUGUST 5, 2021

State opt-out- States’ rights would be preserved with the authority of states to set their own marijuana policies and keep it illegal, but states would not be able to stop product from being transported through their state. There will also be a role for the Treasury and the Consumer Product Safety Commission. Some Thoughts.

Banking 111

Banking Vaping Education DEA 111

Cannabis Law Report

JULY 14, 2021

Legislation opens doors for cannabis policy reform in the current Congress. Cory Booker (D-NJ) and Ron Wyden (D-OR), released draft legislation today that would remove cannabis from the schedule of controlled substances while allowing states to determine their own cannabis policies. WASHINGTON, D.C. But this alone is not enough.

Legislation 71

Legislation Banking History Access 71

Cannabis Law Report

SEPTEMBER 29, 2021

The membership subsequently met with the USDA’s new Hemp Work Group, and White House officials that serve the President on agriculture and drug control policy. Senators) who joined the group in a spirited, interactive discussion on hemp public policy. The national media took notice of some of the highlights: Rep.

Hemp 52

Hemp Banking Legislation Policy 52

Cannabis Law Report

JANUARY 14, 2020

CLICK IMAGE TO ACCESS COMMITTEE INFO PAGE. Senior Policy Advisor, Diversion Control Division. Amidst growing evidence that marijuana can be used to effectively treat post-traumatic stress disorder , this bill from California Democrat Barbara Lee focuses on greatly expanding access to medical marijuana for veterans. Legislation.

Clinical Trials 69

Clinical Trials Programs Access DEA 69

The Joint Blog

JUNE 2, 2020

Cory Gardner (R) of Colorado and Elizabeth Warren (D) of Massachusetts, that would allow states to write their own marijuana policies, remove marijuana from the list in the CSA, and decriminalize it federally. That is the federal policy.” Joe’s latest policy stances on marijuana. Legalize medical marijuana.

Decriminalization 29

Decriminalization Recreational Advocacy Policy 29